Home > Investor Relations > Reports & Downloads > Presentation Materials

Presentation Materials

  • Products/R&D
Jun 01, 2018
Information Meeting on HEMLIBRA®
1. HEMLIBRA® Subcutaneous Injection Product Overview
Hiroshi Motegi, HEMLIBRA® Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
2. Current Status of Hemophilia Treatment and Expectations for HEMLIBRA®
Prof. Midori Shima, M.D., Ph.D.
Department of Pediatrics, Nara Medical University

To view PDF files,
you will need Adobe® Reader® which is available as a free download.